Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
IntegriChain has acquired Cumberland's Life Science Division, a provider of managed services, advisory services and systems integration for contracts, pricing and revenue management.
read more
Under the terms of the agreement, Pfizer has the right to extend the term for up to an additional two years. Financial details of the agreement were not disclosed.
read more
Samsung Biologics entered into a strategic partnership with PharmAbcine for the development and manufacturing of PMC-402 pipeline.
read more
Avacta Group has entered into a collaboration with Cytiva, formerly known as GE Healthcare Life Sciences.
read more
Seneca Biopharma announced the completion of its new cell manufacturing facility in Suzhou, China.
read more
Regeneron and Zai Lab announced a collaboration for the development and commercialization of REGN1979 in mainland China, Hong Kong, Taiwan and Macau.
read more
Almac Clinical Technologies has announced the expedited deployment and support of multiple IRT solutions in support of COVID-19 treatments.
read more
CROMSOURCE has announced that it has initiated its first COVID-19 trial on behalf of a European pharmaceutical company.
read more
WPD announced independent research on WP1122 drug compound found 2-DG to reduce replication of SARS-CoV-2 by 100% in in vitro testing.
read more
Wednesday, April 08, 2020
The U.S. Food and Drug Administration (FDA) has released the following statement regarding the current compounding policy.
read more
Wednesday, April 08, 2020
FFF Enterprises announced its decision to expand its supply of essential medications to support and equip healthcare providers in their battle against COVID-19.
read more
Wednesday, April 08, 2020
Lannett is set to meet with the FDA on June 9, 2020 to plan next steps for the clinical advancement of its biosimilar insulin glargine partnered product candidate.
read more
Wednesday, April 08, 2020
Cambrex has completed an expansion of its biopharmaceutical analysis capabilities at the Durham, North Carolina site.
read more
Wednesday, April 08, 2020
Lodo has achieved a preclinical milestone in its multi-target strategic collaboration with Genentech, a member of the Roche Group.
read more
Wednesday, April 08, 2020
The FDA approved the first generic of Proventil HFA Metered Dose Inhaler, 90 mcg/Inhalation, for treatment or prevention of bronchospasm.
read more